AR016978A1 - Sulfonamidas naftil- y anilidido-substituidas, un proceso para su preparacion, uso de las mismas para la fabricacion de medicamentos y medicamentos que loscontienen - Google Patents

Sulfonamidas naftil- y anilidido-substituidas, un proceso para su preparacion, uso de las mismas para la fabricacion de medicamentos y medicamentos que loscontienen

Info

Publication number
AR016978A1
AR016978A1 ARP990100261A ARP990100261A AR016978A1 AR 016978 A1 AR016978 A1 AR 016978A1 AR P990100261 A ARP990100261 A AR P990100261A AR P990100261 A ARP990100261 A AR P990100261A AR 016978 A1 AR016978 A1 AR 016978A1
Authority
AR
Argentina
Prior art keywords
atoms
alkyl
substituted
straight
hydroxy
Prior art date
Application number
ARP990100261A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR016978A1 publication Critical patent/AR016978A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP990100261A 1998-01-23 1999-01-22 Sulfonamidas naftil- y anilidido-substituidas, un proceso para su preparacion, uso de las mismas para la fabricacion de medicamentos y medicamentos que loscontienen AR016978A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19802439 1998-01-23

Publications (1)

Publication Number Publication Date
AR016978A1 true AR016978A1 (es) 2001-08-01

Family

ID=7855411

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100261A AR016978A1 (es) 1998-01-23 1999-01-22 Sulfonamidas naftil- y anilidido-substituidas, un proceso para su preparacion, uso de las mismas para la fabricacion de medicamentos y medicamentos que loscontienen

Country Status (30)

Country Link
US (1) US6417181B1 (enExample)
EP (1) EP1049666B1 (enExample)
JP (1) JP2002501043A (enExample)
KR (1) KR20010034321A (enExample)
CN (1) CN1294578A (enExample)
AR (1) AR016978A1 (enExample)
AT (1) ATE242207T1 (enExample)
AU (1) AU2420799A (enExample)
BG (1) BG104617A (enExample)
BR (1) BR9907738A (enExample)
CA (1) CA2318182A1 (enExample)
CO (1) CO4810231A1 (enExample)
DE (1) DE59905829D1 (enExample)
EE (1) EE200000432A (enExample)
ES (1) ES2201666T3 (enExample)
GT (1) GT199900010A (enExample)
HR (1) HRP20000532A2 (enExample)
HU (1) HUP0200918A2 (enExample)
ID (1) ID25448A (enExample)
IL (1) IL137159A0 (enExample)
NO (1) NO20003601L (enExample)
NZ (1) NZ505900A (enExample)
PE (1) PE20000181A1 (enExample)
PL (1) PL341815A1 (enExample)
SK (1) SK11012000A3 (enExample)
SV (1) SV1999000006A (enExample)
TR (1) TR200002140T2 (enExample)
TW (1) TW461880B (enExample)
WO (1) WO1999037609A1 (enExample)
ZA (1) ZA99473B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919793A1 (de) * 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19934295A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Kristallmodifikation III von N-(4-(5-Dimethylamino-naphthalin-1-sulfonyl-amino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamid
DE19934321A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Naphthyl-substituierte Sulfonamide
EP1402890B1 (en) * 2001-06-08 2008-01-09 Institute of Medicinal Molecular Design, Inc. Sulfonamide derivatives
GB2403474B (en) * 2002-04-18 2006-10-11 Inst Med Molecular Design Inc Amide derivatives
TW200510311A (en) 2002-12-23 2005-03-16 Millennium Pharm Inc CCr8 inhibitors
EP1590327A1 (en) 2002-12-23 2005-11-02 Millennium Pharmaceuticals, Inc. Ccr8 inhibitors
US7491827B2 (en) * 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
US7425527B2 (en) 2004-06-04 2008-09-16 The Procter & Gamble Company Organic activator
RU2452490C1 (ru) * 2010-12-27 2012-06-10 Виктор Вениаминович Тец Лекарственное средство с активностью против семейства герпес-вирусов
AU2013257951A1 (en) 2012-05-11 2015-01-22 Akron Molecules Ag Use of compounds for the treatment of pain
RU2530587C1 (ru) 2013-06-07 2014-10-10 Виктор Вениаминович Тец Способ лечения заболеваний кожи и слизистых оболочек, вызываемых вирусами простого герпеса 1-го и 2-го типов
RU2605602C1 (ru) 2015-09-15 2016-12-27 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения натриевой соли (2,6-дихлорфенил)амида карбопентоксисульфаниловой кислоты
CN112062901B (zh) * 2020-08-14 2023-03-21 合肥工业大学 一种螺旋荧光异腈共聚物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2423572A (en) * 1946-05-03 1947-07-08 Du Pont Naphtholsulfonamidobenzaldehydes and acetals thereof
US2949479A (en) * 1954-06-17 1960-08-16 Dainippon Pharmaceutical Co Acyl derivatives of aminonaphthalene-sulfonamide
US3925347A (en) 1967-07-24 1975-12-09 Polaroid Corp Processes of synthesizing azo compounds
US3482971A (en) 1967-07-24 1969-12-09 Polaroid Corp Scavengers for oxidized developing agent
US4035401A (en) 1970-03-30 1977-07-12 Polaroid Corporation Intermediates for photographic dyes
JPS5499433A (en) 1978-01-20 1979-08-06 Konishiroku Photo Ind Co Ltd Dye image formation method
EP0284130B1 (en) 1987-03-19 1991-06-26 Agfa-Gevaert N.V. Organic compounds for use in a dye diffusion transfer process and photographic elements incorporating them
AU5175490A (en) * 1989-02-27 1990-09-26 Du Pont Merck Pharmaceutical Company, The Novel sulfonamides as radiosensitizers
DE4331134A1 (de) 1993-09-14 1995-03-16 Bayer Ag Neue antiviral wirksame Pseudopeptide
EP0684515A1 (en) 1994-05-27 1995-11-29 Eastman Kodak Company Photographic element and process incorporating a high dye-yield image coupler providing improved granularity

Also Published As

Publication number Publication date
HRP20000532A2 (en) 2001-02-28
PE20000181A1 (es) 2000-04-12
BG104617A (en) 2001-04-30
WO1999037609A1 (de) 1999-07-29
PL341815A1 (en) 2001-05-07
EE200000432A (et) 2001-12-17
IL137159A0 (en) 2001-07-24
NO20003601L (no) 2000-09-14
ATE242207T1 (de) 2003-06-15
CN1294578A (zh) 2001-05-09
SV1999000006A (es) 2000-10-09
ES2201666T3 (es) 2004-03-16
GT199900010A (es) 2000-07-15
HUP0200918A2 (en) 2002-09-28
ID25448A (id) 2000-10-05
TR200002140T2 (tr) 2000-12-21
KR20010034321A (ko) 2001-04-25
SK11012000A3 (sk) 2001-01-18
TW461880B (en) 2001-11-01
EP1049666A1 (de) 2000-11-08
AU2420799A (en) 1999-08-09
CO4810231A1 (es) 1999-06-30
DE59905829D1 (de) 2003-07-10
NO20003601D0 (no) 2000-07-13
EP1049666B1 (de) 2003-06-04
US6417181B1 (en) 2002-07-09
ZA99473B (en) 1999-07-27
BR9907738A (pt) 2000-10-17
NZ505900A (en) 2002-02-01
CA2318182A1 (en) 1999-07-29
JP2002501043A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
AR023703A1 (es) N-carboniloximetilesteres de nitroetilendiaminas y nitroguanidinas, proceso para su preparacion, composicion parasiticida, una preparacion en combinacionpara controlar parasitos en animales de sangre caliente, uso de dichos compuestos y compuestos intermediarios para su uso en dicho proceso de prepa
ES2183548T3 (es) Dihidropirimidinas.
AR016736A1 (es) Derivados sustituidos de pirazol, procedimiento para su preparacion, su uso en la manufactura de un medicamento, medicamentos que los contienen,procedimiento para preparar dichos medicamentos
FI965126A7 (fi) Tri-substituoidut PDE IV -inhibiittoreina hyödylliset fenyylijohdannaiset
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
ES2110421T3 (es) O-bencil-oximeteres y los agentes protectores de las plantas que contienen estos compuestos.
CY1109072T1 (el) Βητα κρυσταλλικη μορφη του υδροχλωρικου αλατος της ιβαμπραδινης, μεθοδος παρασκευης αυτου και φαρμακευτικης συνθεσεις που το περιεχουν
ES2136037A1 (es) Inhibidores de sulfamida-metaloproteasa
CO4771105A1 (es) Procedimiento para la preparacion de derivados de la clase de los taxoides
NO955256D0 (no) Fenylheterosykluser som syklooksygenase-2-inhibitorer
DK249389D0 (da) 2-acylamino-benzothiazol-forbindelser og deres anvendelse til fremstilling af laegemidler til behandling af tumorer
FI970246A7 (fi) Dihydrobentsofuraanit
FI971104A0 (fi) Menetelmä COX-inhibiittoreina käyttökelpoisten fenyyliheterosyklien valmistamiseksi
ECSP055582A (es) Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor
IS7098A (is) 4-fenýlpíperidín efnasambönd
CO4900061A1 (es) Piridinas y bifenilos substituidos
MX9303145A (es) 7-(2-aminoetil)benzotiazolonas.
ATE239678T1 (de) Additive für zement enthaltende mineralische baustoffe
DK1105386T3 (da) Hidtil ukendt saltform af pantoprazol
CY1108793T1 (el) Καμπτοθεκινες με τροποποιημενο λακτονικο δακτυλιο
ES2255190T3 (es) Compuestos indol 2,3-sustituidos como inhibidores de cox-2.
CO4810231A1 (es) Nuevas sulfonamidas naftil- y anilido - substituidas
CY1109085T1 (el) Νεα αλατα
PE20001083A1 (es) Derivados de mononitrato de isosorbide
CO5590952A2 (es) Derivados de aminoacetonitrilo y su uso para controlar parasitos